PD-1 Inhibitors Linked to Better Outcomes in NK/T Lymphoma

Published Date: 05 May 2026

A real-world study assesses survival outcomes when adding PD-1 inhibitors to asparaginase-based regimens in patients with extranodal natural killer/T-cell lymphoma.

Read Full News

Latest News

HTTP error: 503 HTTP error: 503

News All Time

HTTP error: 503 HTTP error: 503HTTP error: 503HTTP error: 503 HTTP error: 503 HTTP error: 503 HTTP error: 503
Featured News
Featured Articles
Featured Events
Featured KOL Videos

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot